Rising Star: Goodwin's Heath Ingram
Law360 (August 27, 2026, 4:03 PM EDT) -- Heath Ingram of Goodwin Procter LLP advised Avadel Pharmaceuticals on its launch of a U.S. Food and Drug Administration-approved narcolepsy drug and then its $2.37 billion sale to fellow Irish drugmaker...
To view the full article, register now.